BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pharmacogenetics
,
Cisplatin
,
rs4950928
,
FXYD4
,
glucose metabolic process
,
Influenza
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
GCGR
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Liver
Granulocyte-macrophage progenitor cell of bone marrow
Sigmoid colon
Macrophage of peripheral blood
Fetal liver
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Liver cancer
Disorder of glucose metabolism
Whipple's disease
Brucellosis
Coronavirus infection
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
degrasyn
Digitoxin
Dicumarol
Heptachlor Epoxide
Lamivudine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
TET1
SS18
P2RX5
ONECUT1
FH
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Incomplete Hydrogenation by Geranylgeranyl Reductase from a Proteobacterial Phototroph Halorhodospir…
Constructing tailored isoprenoid products by structure-guided modification of geranylgeranyl reducta…
The ubiquitination status of the glucagon receptor determines signal bias.
Tail engagement of arrestin at the glucagon receptor.
Negative allosteric modulation of the glucagon receptor by RAMP2.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pharmacogenomics of GLP1 Receptor Agonists
Acute Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon
A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisi…
A First in Human (FIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodyn…
Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ